September 6 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma [BUL:SFA] said that its consolidated net profit rose to 43.4 million levs ($22.01 million/22.2 million euro) in the first half of 2022 from 32.2 million levs a year earlier.